Contribution of Inflammation to Fat Redistribution and Metabolic Disturbances in HIV-1 Infected Patients

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|16|30|3361-3371

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.16, Iss.30, 2010-10, pp. : 3361-3371

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacogenetics of the Metabolic Disturbances and Atherosclerosis Associated with Antiretroviral Therapy in HIV-Infected Patients

By  

Current Pharmaceutical Design, Vol. 16, Iss. 30, 2010-10 ,pp. : 3379-3389

Bentham Science Publishers

Access to resources Recommend Favorite

Lipotoxicity on the Basis of Metabolic Syndrome and Lipodystrophy in HIV-1-Infected Patients Under Antiretroviral Treatment

By  

Current Pharmaceutical Design, Vol. 16, Iss. 30, 2010-10 ,pp. : 3372-3378

Bentham Science Publishers

Access to resources Recommend Favorite

Rosiglitazone in HIV-1-infected patients with insulin resistance

By  

Inpharma, Vol. 1, Iss. 1366, 2002-01 ,pp. : 19-19

Adis International

Access to resources Recommend Favorite

Maraviroc MOTIVATEs virological response in HIV-1-infected patients

By  

Inpharma, Vol. 1, Iss. 1578, 2007-01 ,pp. : 7-8

Adis International

Access to resources Recommend Favorite

HIV-1 Infected Patients have Antibodies Recognizing Folded Tat

By  

Infectious Disorders - Drug Targets (Formerly Current Drug Targets - Infectious Disorders), Vol. 11, Iss. 1, 2011-02 ,pp. : 57-63

Bentham Science Publishers

Access to resources Recommend Favorite